Pau Montesinos

109PUBLICATIONS
440CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Medical molecular engineering of nucleic acids and proteinsOtorhinolaryngology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (109)

|Sep 26, 2026
CD84 Expression Across Disease Stages and Leukemic Subpopulations in Acute Myeloid Leukemia.

|Sep 18, 2026
Intensive Chemotherapy and Tyrosine Kinase Inhibitor in Patients with De Novo BCR::ABL1+ Acute Myeloid Leukemia.

|Sep 15, 2026
Donor NKG2A/NKG2C Immunophenotype Influences the GMP-Compliant Manufacturing Potential of NK Cells for Adoptive Immunotherapy.

|Aug 31, 2026
Real-World Outcomes of Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: The PETHRATIFY Study.

|Jun 30, 2026
Quizartinib in Combination With FLAG-IDA for Relapsed or Refractory Acute Myeloid Leukemia (FLAG-QUIDA): A PETHEMA Phase I-II Trial.

|Jun 08, 2026
Prognostic impact of variant allele frequency in intensively treated patients with NPM1-mutated AML: a PETHEMA study.

Pageof 19

Frequent Collaborators

24 joint publications

David Martínez-Cuadrón

18 joint publications

Juan-Miguel Bergua

15 joint publications

Antonio Solana-Altabella

14 joint publications

Juan Eduardo Megías-Vericat